LncRNA SNHG15 promotes the proliferation of nasopharyngeal carcinoma via sponging miR-141-3p to upregulate KLF9

被引:3
作者
Yi, T-W [1 ]
Lv, X-X [1 ]
Fan, H. [1 ]
Zan, N. [1 ]
Su, X-D [1 ]
机构
[1] Peoples Hosp Leshan, Dept Oncol & Hematol, Leshan, Peoples R China
关键词
Nasopharyngeal carcinoma; SNHG15; Proliferation; MiR-141-3p; KLF9; LONG NONCODING RNA; CELL-PROLIFERATION; CANCER CELLS; LUNG-CANCER; INVASION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Long non-coding RNAs (IncRNAs) have been identified to exert an oncogenic or anti-tumor function in malignant tumors. LncRNA SNHG15 is verified to be an oncogene in hepatocellular carcinoma, colorectal cancer, and prostate cancer. In this paper, we mainly investigate the potential influence of SNHG15 on the progression of nasopharyngeal carcinoma (NPC). PATIENTS AND METHODS: SNHG15 levels in NPC tissues and cell lines were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Correlation between SNHG15 level and prognosis of NPC patients was evaluated by the Kaplan-Meier method. Regulatory effects of SNHG15 on proliferative, colony formation abilities, and apoptosis of SUNE1 and CNE1 cells were assessed through a series of functional experiments. Potential miRNAs binding SNHG15 and the downstream gene of the microRNA (miRNA) were predicted by bioinformatics method, which was confirmed by Dual-Luciferase reporter gene assay and Western blot. RESULTS: SNHG15 was upregulated in NPC tissues and cells. High level of SNHG15 indicated worse survival in NPC patients. Knockdown of SNHG15 markedly suppressed proliferative ability and induced apoptosis in SUNE1 and CNE1 cells. It is verified that miR-141-3p was the direct target binding SNHG15, and KLF9 was the downstream gene of miR-141-3p. SNHG15 was demonstrated to be a ceRNA to upregulate KLF9 by competitively binding miR-141-3p. CONCLUSIONS: SNHG15 is upregulated in NPC tissues, and this aggravates the progression of NPC by absorbing miR-141-3p to upregulate KLF9.
引用
收藏
页码:6744 / 6751
页数:8
相关论文
共 33 条
  • [1] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [2] Long noncoding RNAs and the genetics of cancer
    Cheetham, S. W.
    Gruhl, F.
    Mattick, J. S.
    Dinger, M. E.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2419 - 2425
  • [3] Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC
    Chen, Su-xiu
    Yin, Jun-feng
    Lin, Bao-chai
    Su, Hua-fang
    Zheng, Zhen
    Xie, Cong-ying
    Fei, Zheng-hua
    [J]. TUMOR BIOLOGY, 2016, 37 (05) : 6801 - 6812
  • [4] RETRACTED: MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-beta 1/mTOR axis and HOXC6 in nasopharyngeal carcinoma (Retracted article. See vol. 34, pg. 695, 2022)
    Cheng, Jin-Zhang
    Chen, Jun-Jun
    Wang, Zong-Gui
    Yu, Dan
    [J]. CANCER BIOMARKERS, 2018, 23 (01) : 107 - 123
  • [5] CD90+liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
    Conigliaro, Alice
    Costa, Viviana
    Lo Dico, Alessia
    Saieva, Laura
    Buccheri, Simona
    Dieli, Francesco
    Manno, Mauro
    Raccosta, Samuele
    Mancone, Carmine
    Tripodi, Marco
    De Leo, Giacomo
    Alessandro, Riccardo
    [J]. MOLECULAR CANCER, 2015, 14
  • [6] From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
    Dhamija, Sonam
    Diederichs, Sven
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (02) : 269 - 280
  • [7] Dong YZ, 2018, EUR REV MED PHARMACO, V22, P2671, DOI 10.26355/eurrev_201805_14963
  • [8] Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a
    Finlay-Schultz, J.
    Cittelly, D. M.
    Hendricks, P.
    Patel, P.
    Kabos, P.
    Jacobsen, B. M.
    Richer, J. K.
    Sartorius, C. A.
    [J]. ONCOGENE, 2015, 34 (28) : 3676 - 3687
  • [9] Hu Y, 2019, ORAL ONCOL, V99
  • [10] Hughes J, 2012, RHINOLOGY, V50, P115, DOI [10.4193/Rhin11.239, 10.4193/Rhino11.239]